Redefining quality--implications of recent clinical trials

N Engl J Med. 2008 Jun 12;358(24):2537-9. doi: 10.1056/NEJMp0803740. Epub 2008 Jun 6.

Authors

Harlan M Krumholz¹, Thomas H Lee

Affiliation

¹ Yale University School of Medicine, New Haven, CT, USA.

PMID: 18539915
DOI: 10.1056/NEJMp0803740

No abstract available

Publication types

Comment

MeSH terms

Anticholesteremic Agents / adverse effects
Cardiovascular Diseases / prevention & control
Clinical Trials as Topic / standards*
Diabetes Mellitus, Type 2 / drug therapy*
Drug Therapy, Combination
Humans
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use*
Quality of Health Care*
Quinolines / adverse effects
Risk Factors

Substances

Anticholesteremic Agents
Hypoglycemic Agents
Quinolines
torcetrapib